| scholarly article | Q13442814 |
| P2093 | author name string | Ghada El Sagheer | |
| Lamiaa Hamdy | |||
| Asmaa Ahmad | |||
| Elwy Soliman | |||
| P2860 | cites work | The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients | Q42999928 |
| Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. | Q43034614 | ||
| High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. | Q43042247 | ||
| Serum lipids and chronic hepatitis C genotype 4: interaction and significance | Q43047666 | ||
| Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis | Q43047910 | ||
| Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients | Q45396986 | ||
| Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment | Q47195235 | ||
| Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways | Q77807989 | ||
| The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses | Q84114728 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids | Q29620653 | ||
| Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial | Q33798375 | ||
| Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma | Q34544988 | ||
| Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients | Q35122536 | ||
| Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. | Q35861534 | ||
| Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment | Q36146807 | ||
| Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration | Q36837502 | ||
| Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease | Q37015738 | ||
| Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 | Q37155511 | ||
| Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b. | Q37743001 | ||
| Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. | Q38164114 | ||
| Safety of direct antiviral agents in the management of hepatitis C. | Q38818416 | ||
| Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO). | Q39146320 | ||
| Effect of antiviral therapy for HCV on lipid levels | Q40522764 | ||
| Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C? | Q42919523 | ||
| Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. | Q42978148 | ||
| Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. | Q42980606 | ||
| Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. | Q42984313 | ||
| Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients | Q42995429 | ||
| P433 | issue | 1 | |
| P921 | main subject | insulin resistance | Q1053470 |
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | 1435124 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Libyan journal of medicine | Q26854001 |
| P1476 | title | Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs | |
| P478 | volume | 13 |
Search more.